AboutContact us
dotsbydots
SEARCHCONTACT US

Buzz

Most popular

Daily
Weekly
1
Inside the mind of a Nobel physicist: John Martinis on the future of quantum computing
2
Check Point raises $1.75 billion, potentially eyeing AI expansion
3
Hapag-Lloyd eyes ZIM acquisition, workers push back
4
Sequoia’s Shaun Maguire says Israel risks losing “a war it can’t see”
5
Nice puts Actimize up for sale at a $1.5-2 billion price tag
More news

Biotech

20 stories about Biotech
לייפנפלד )מימין( וכהן־סולל במשרדי NeuroKairs בתל אביב. "יכולנו לשבת כמו כל הסטארט־ אפים באחד ממגדלי ההייטק, אבל חשוב לנו לא להוציא כסף על מה שלא חובה"

The women turning a blood sample into a map of the depressed brain

27.11.25|Sophie Shulman
Tel Aviv-based NeuroKaire is using “brain-in-a-dish” models to personalize antidepressants, and is now shifting from years of research to full-scale commercialization in Israel and the U.S.
Cassidy Bio founders

Cassidy Bio raises $8M Seed round to build AI-first platform for designing genetic medicines

20.11.25|CTech
Founders include CRISPR, AI, and biotech veterans focused on improving safety and specificity in therapy development.
Noam Solomon Immunai

Immunai strikes $85M deal with AstraZeneca to develop new IBD drug target

16.10.25|CTech
AI biotech expands partnership after uncovering novel immune target with its machine learning platform.
מימין מושיק כהן קוטנר נדב בחנוף חברת אומניקס מדיקל

Omnix Medical raises $25 million Series C to tackle drug-resistant infections

15.10.25|CTech
Israeli biotech secures funding to complete Phase II trials for its novel antimicrobial peptide therapy.
רוש ROCHE

Roche strikes $3.5 billion deal for U.S.-Israeli biotech 89bio

18.09.25|CTech
Founded in 2018 from Teva’s pipeline, the biotech firm is set to become a centerpiece in Roche’s obesity strategy.
טליה כהן סולל ו דפנה לייפנפלד

Israeli startup NeuroKaire launches world’s first blood test to personalize depression treatment

09.09.25|Maayan Cohen Rozen
BrightKaire uses AI and stem-cell technology to match patients with effective medications, potentially ending years of trial-and-error prescribing.
בדיקת דם מעבדה פתולוגית Pathology laboratory

Israeli biotech Senseera raises $7.1 million Seed round for liquid biopsy platform

07.01.25|CTech
The GEM BIOMARKERS technology aims to revolutionize diagnostics in oncology, immunology, and liver disease management. 
Converge Bio founders

Converge Bio raises $5.5M in Seed funding to speed up drug discovery and development with GenAI

20.11.24|CTech
The Israeli startup's platform uses large language models (LLMs) trained on biological and chemical data (DNA, RNA, protein sequences, and small molecules) to help biotech and pharmaceutical companies discover and develop better-performing drugs in less time.
Noam Solomon Immunai

Immunai and Teva launch multi-tear AI collaboration for smarter drug development

14.11.24|CTech
The partnership will utilize Immunai’s cutting-edge immune system mapping tools to enhance precision in immunology and oncology trials.  
Enzymit team

Enzymit raises $10 million Series A for cell-free bio-production technology

25.09.24|CTech
The Israeli startup is building a cell-free production platform that aims to make bioproduction faster, simpler, cost-effective, and scalable. 
MNDL Bio Team

Israel’s MNDL Bio is taking on a $116 billion market

08.09.24|CTech
The company has raised a total of $2 million for its AI-powered gene optimization platform
BioGenCell

BioGenCell pioneers revolutionary cell therapy for microvascular disease

11.07.24|Ariela Karmel
CEO Yael Porat spoke to CTech about the Israeli biotech company’s groundbreaking cell therapy technology for the common and debilitating disease whose primary treatment today is amputation 
מייסדי Nucleai

Spatial AI biomarker startup Nucleai raises $14 million led by Merck’s VC arm

03.04.24|CTech
Leveraging AI and machine learning, Nucleai analyzes pathology images and spatial data at the cellular and tissue levels. The proprietary technology extracts detailed patterns and features from medical images, offering insights into the tumor microenvironment, cellular morphology, and spatial relationships between different cell types
ד"ר תומר ברונשטיין סמנכ"ל חדשנות ופיתוח תאגידי בבונוס ביוגרופ

Biotech 2024: Opportunities and challenges for Israeli companies

22.01.24|Tomer Bronshtein
“Despite their strong clinical data and established R&D programs, Israeli biotech companies are undervalued. Following two years of economic downturn, these companies now present attractive investment opportunities,” writes Dr. Tomer Bronshtein, VP for Innovation and Corporate Development at Bonus Biogroup
Ben Rabinowitz Mati Gill

Amiti Ventures joins pharma venture studio AION Labs as a Strategic Partner

08.01.24|James Spiro
The Israeli VC firm joins the Israel-based alliance of AstraZeneca, Merck, Pfizer, Teva, Israel Biotech Fund, BioMed X and Amazon Web Services
Mana.bio founders

Biotech startup Mana.bio raises $19.5 million Seed to accelerate programmable drug delivery

12.10.23|CTech
The company, co-founded by Yogev Debbi, Roy Nevo, Avi Schroeder, and Kira Radinsky, unveiled its AI-based lipid nanoparticle (LNP) delivery platform to accelerate the development of nucleic acid-based therapeutics and vaccines
Scala Biodesign

Scala Biodesign exits stealth with $5.5 million in Seed to engineer future proteins

11.09.23|James Spiro
By fusing physics-based modeling, AI, and biological data analysis, Scala helps companies develop new medicines and foods faster and cheaper than before
IntraGel Founders

Intragel hopes to treat the 10% of inoperable cancer patients

03.08.23|CTech
The company has raised a total of $2 million for its first product, TumoCure, designed for solid tumors found in more than 17 million people.
מוסף שבועי 6.7.23 פרופ' צ'ארלס ברנר

"We won't get eternal life. Scientists who promise it are just selling BS"

16.07.23|Roni Dori
Forget about anti-aging treatments or drinking red wine. Prof. Charles Brenner bursts the balloon inflated by the booming longevity industry, and explains why there is no way to defeat death
Sharon Handelman-Gottlieb Adi eshel

From passion to innovation: Unleashing the power of FemTech in Israel's health landscape

13.06.23|Ariela Karmel
Sharon Handelman-Gotlib's journey to co-founding Shela and the promise of transformative women's health solutions
More Articles